Filing Details

Accession Number:
0001161697-22-000560
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-23 17:00:19
Reporting Period:
2022-11-21
Accepted Time:
2022-11-23 17:00:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369568 Catalyst Pharmaceuticals Inc. CPRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1109775 H Philip Coelho 355 Alhambra Circle, Suite 801
Coral Gables FL 33134
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Disposition 2022-11-21 70,000 $15.23 179,553 No 4 S Direct
Common Stock, Par Value $0.001 Per Share Disposition 2022-11-22 20,001 $17.30 159,552 No 4 S Direct
Common Stock, Par Value $0.001 Per Share Disposition 2022-11-23 9,999 $17.45 149,553 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Shares were sold for personal reasons. Shares were not sold as a result of any disagreement with the Company and Mr. Coelho remains a director of the Company.
  2. Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.01 to $15.59 per share.
  3. Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $17.28 to $17.335 per share.